Company Filing History:
1 out of 16 
1 out of 222 
Years Active: 2015-2020
Title: Innovations by Kyung-Hee Chun in Cancer Therapeutics
Introduction
Kyung-Hee Chun is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer research, particularly in developing therapeutic compositions for breast cancer. With a total of 2 patents, Chun's work focuses on innovative methods to combat cancer and improve patient outcomes.
Latest Patents
Chun's latest patents include groundbreaking methods for treating cancer. One patent details therapeutic compositions for breast cancer that contain a protein kinase D1 inhibitor. This method involves administering an effective amount of a protein kinase D1 expression or activity inhibitor to a subject with cancer. Additionally, it outlines a method for measuring the expression or activity of protein kinase D1, which provides valuable information regarding breast cancer prognosis. Another patent describes a method for screening cancer therapeutic agents using galectin-3, GSK-3β, and fascin-1. This method aims to identify novel cancer therapeutic agents that can down-regulate galectin-3 and fascin-1 or disrupt their interaction with GSK-3β.
Career Highlights
Chun has worked with esteemed institutions such as the Sookmyung Women's University Industry-Academic Cooperation Foundation and the National Cancer Center. His research has been pivotal in advancing cancer treatment methodologies and understanding cancer biology.
Collaborations
Chun has collaborated with notable colleagues, including Jong Hoon Park and Do Yeon Kim, who have contributed to his research endeavors.
Conclusion
Kyung-Hee Chun's innovative work in cancer therapeutics showcases his commitment to improving treatment options for patients. His patents reflect a deep understanding of cancer biology and a dedication to advancing medical science.